Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells
Authors
Keywords
Large intergenic noncoding RNA regulator of reprogramming, Breast cancer, Epithelial-mesenchymal transition, 5-Fluorouracil, Paclitaxel, MDA-MB231 cell, Invasion
Journal
TUMOR BIOLOGY
Volume 37, Issue 8, Pages 10861-10870
Publisher
Springer Nature
Online
2016-02-16
DOI
10.1007/s13277-016-4909-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
- (2015) Qiong Wu et al. Oncotarget
- Sheep, wolf, or werewolf: Cancer stem cells and the epithelial-to-mesenchymal transition
- (2013) Jeffrey T. Chang et al. CANCER LETTERS
- Endogenous miRNA Sponge lincRNA-RoR Regulates Oct4, Nanog, and Sox2 in Human Embryonic Stem Cell Self-Renewal
- (2013) Yue Wang et al. DEVELOPMENTAL CELL
- Adjuvant Systemic Therapies in Breast Cancer
- (2013) Leonel F. Hernandez-Aya et al. SURGICAL CLINICS OF NORTH AMERICA
- Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil
- (2013) B S Vinod et al. Cell Death & Disease
- Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior
- (2012) Carole Saison et al. NATURE GENETICS
- Genome-wide association analysis identifies three new breast cancer susceptibility loci
- (2012) Maya Ghoussaini et al. NATURE GENETICS
- Chemoresistance to 5-fluorouracil induces epithelial–mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells
- (2011) Weijia Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Breast Cancer
- (2011) ASHLEY STUCKEY CLINICAL OBSTETRICS AND GYNECOLOGY
- Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis
- (2011) A. Pauli et al. GENOME RESEARCH
- Prospects for Riboswitch Discovery and Analysis
- (2011) Ronald R. Breaker MOLECULAR CELL
- lincRNAs act in the circuitry controlling pluripotency and differentiation
- (2011) Mitchell Guttman et al. NATURE
- Large non-coding RNAs: missing links in cancer?
- (2010) M. Huarte et al. HUMAN MOLECULAR GENETICS
- Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells
- (2010) Sabine Loewer et al. NATURE GENETICS
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Evolution and Functions of Long Noncoding RNAs
- (2009) Chris P. Ponting et al. CELL
- Long noncoding RNAs: functional surprises from the RNA world
- (2009) J. E. Wilusz et al. GENES & DEVELOPMENT
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
- (2009) Mitchell Guttman et al. NATURE
- Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
- (2009) Hanna Fredholm et al. PLoS One
- Breast Cancer Before Age 40 Years
- (2009) Carey K. Anders et al. SEMINARS IN ONCOLOGY
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA
- (2008) Wenqiang Yu et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now